By Myles Starr
Supply shortages of some commonly used agents in cancer treatments are placing patients’ survival at risk. A group of concerned parties including the American Cancer Society (ACS), ACS Cancer Action Network and USP Convention held a Sept. 26 virtual summit on the issue. The meeting was followed by a call to action, which organizers are encouraging interested stakeholders to sign.
“There is absolutely a crisis regarding these absolutely essential backbone therapies for